As of 2025, retatrutide has not received a UK marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA), which is the licensing authority for Great Britain
Funding This work was supported by grants from the National Natural Science Foundation (81972259, 82273394), the Clinical Trials Fund from Nanjing Drum Tower Hospital and the Affiliated Hospital of Nanjing University Medical School (2024-LCYJ-PY-01), Suzhou Municipal Health Commission (SKYD2022034), and the discipline construction and support project (XKTJ-JD202006) of the Second Affiliated Hospital of Soochow University
We do not use research chemicals or unregulated products
Pricing was set at $149 per month for self-pay patients, $25 with commercial insurance, and $50 for Medicare beneficiaries starting July 1
Cet quilibre est important pour la dfense contre les infections et pour viter les maladies auto-immunes
Semaglutide is a GLP-1 receptor agonist, which is a type of medication that mimics a natural hormone called glucagon-like peptide-1 (GLP-1)